Tilly

LearnShot day

Mounjaro and Zepbound: a week, day by day

Day 1 to 3, the climb. Day 4 to 5, the good stretch. Day 6 to 7, the fade.Tilly, the app's turtle, walking mid-step and holding an injector pen like a baton

Tirzepatide is the medicine in both Mounjaro and Zepbound: the same molecule, the same weekly injection, the same doses. Mounjaro is the name it carries for type 2 diabetes and Zepbound for weight; the week feels the same under either. And the week has a shape. Knowing it turns “why do I feel awful today” into “it is day 2”, which is a smaller thing to carry. What follows is that shape, from the label and from what people who log their days see, and none of it is medical advice.

Day 1 to 3: the climb

After the injection, tirzepatide is absorbed slowly from under the skin. The label gives the median time to the highest level in the blood as 24 hours, with a range of 8 to 72 hours.1 So for most people the peak lands on day 2, for some on the evening of day 1, for others as late as day 3.

The peak is where the side effects live. The stomach empties slowest when the level is highest, and that is the queasy feeling, the fullness after three bites, the coffee that smells wrong. The label is plain about when this happens: the majority of nausea, vomiting and diarrhoea events occurred during dose escalation and decreased over time.1 If you are in the first month on a new dose, the climb is at its steepest now and will be gentler in a few weeks.

What helps on these days is the same as on any GLP-1: small, plain meals, protein before anything else, sips rather than glasses, and staying upright after eating. There is a whole page on the day 2 feeling and what to do with it.

Day 4 to 5: the good stretch

By day 4 the level is past its peak but still high. The stomach has found its pace, the appetite is quiet without the nausea, and most people describe these as the easy days: eating is possible, the food noise is off, and a normal-sized meal is not a project.

This is the window to get the protein in. On a small appetite it is the thing that slips first, and these are the days when it does not have to. Cook the chicken on day 4. Freeze some of it for day 2.

Seven days, one shape. After three weeks written down, you know which day is which before it arrives.

Day 6 to 7: the fade

Tirzepatide has an elimination half-life of about five days; the Zepbound label says five to six in people with obesity.1 That means the level falls by about half every five days. By the end of the week it is at its lowest point of that week, just before the next dose brings it back up. The stomach empties a little faster again, and for many people the appetite, and the thoughts about food, come back a little on day 6 and 7. That is not the medication failing. It is the medication fading on schedule.

Two things soften the fade. First, five days is still a long half-life, so a good deal of the previous dose is in the body when the next one goes in. Second, the label says steady-state levels were reached after four weeks of once-weekly dosing.1 After the first month, each shot lands on top of what is still there, and the end-of-week dip is shallower than it was at the start.

For comparison, semaglutide, the medicine in Ozempic and Wegovy, peaks 1 to 3 days after the dose and has a half-life of about a week,3 so its week has the same shape with a slightly gentler fade. The shorter half-life of tirzepatide also means it leaves the body sooner if you ever stop, which is a conversation for your prescriber, not this page.

The first month, and every step up

The label sets out the dose steps, and they are the reason the first weeks feel the way they do.

  • The starting dose is 2.5 mg once weekly for 4 weeks. The label says this dose is for starting only and is not approved as a maintenance dose.1
  • After 4 weeks, the dose goes to 5 mg. From there it may be increased in 2.5 mg steps, after at least 4 weeks on the current dose.1
  • The maintenance doses for weight are 5, 10 or 15 mg, and 15 mg is the maximum.1 The label also says that if a maintenance dose is not tolerated, a lower one should be considered.1

Each step is a new, higher climb for the body to get used to, which is why the four weeks matter and why day 2 after an increase can feel like the first week again. Whether and when you step up is your prescriber’s decision. The label gives them the ladder; they decide the pace.

The numbers from the Zepbound weight-reduction trials, at 5, 10 and 15 mg against placebo: nausea in 25, 29 and 28 people out of 100, against 8; diarrhoea in 19, 21 and 23, against 8; vomiting in 8, 11 and 13, against 2; constipation in 17, 14 and 11, against 5.1 Some kind of gastrointestinal side effect was reported by 56 in 100 on every dose, against 30 on placebo, and between 2 and 4 in 100 stopped because of them, against fewer than 1 on placebo.1 In the Mounjaro trials, in people with type 2 diabetes, the same effects were reported less often: nausea in 12 to 18 out of 100 depending on the dose, against 4.2 Same molecule, different people, different trials.

Moving the day, missing the day

Life does not always fall on the same weekday. The label has two rules for that, and both are worth knowing before you need them.

  • A missed dose can be taken as soon as possible within 4 days, that is 96 hours, of the missed time. If more than 4 days have passed, the label says to skip it and take the next dose on the usual day.1
  • The day of the week can be changed if necessary, as long as there are at least 3 days, 72 hours, between the two doses.1

A pen or vial can be kept at room temperature, up to 30 °C, for a total of 21 days,1 which covers most trips. All of this is what the label allows; whether it is right for you this week is a question for the person who prescribed it, and a quick one to ask.

What to write down

The shape above is the average. Yours has its own timing, and the only way to know it is to write three weeks of mornings down: the shot, the day of the week, how you felt when you woke up, and what you managed to eat. After three weeks you will see it. Your day 2 may be a day 3. Your fade may start on day 5. Your prescriber will get more out of “queasy on day 2, fine by day 4, hungry by day 6” than out of “it was hard”.

Tilly keeps that journal, draws the week under the title so you can see where you are in it, and notices when the hard day is always the same day. It never tells you what dose to take, when to step up, or whether to move the shot. It tells you what your weeks have looked like, which is the thing worth bringing to the appointment.

Questions

Is the week different on Mounjaro and on Zepbound?

No. They are the same molecule, tirzepatide, at the same doses, with the same peak, half-life and dose rules. The side-effect percentages differ because they were measured in different trials, in people with type 2 diabetes for Mounjaro and in people with obesity for Zepbound.

Why is my day 2 worse right after a dose increase?

Each step up is a new, higher peak for the body to get used to. The label says most nausea, vomiting and diarrhoea happened during dose escalation and decreased over time, which is why the steps are at least four weeks apart.

Does the shape of the week change once I am on a steady dose?

It softens. After about four weekly doses the level reaches a steady state, so each new shot lands on top of what is still there and the dip at the end of the week is shallower than in the first month.

Sources

  1. Zepbound (tirzepatide) prescribing information, Eli Lilly
  2. Mounjaro (tirzepatide) prescribing information, Eli Lilly
  3. Ozempic (semaglutide) prescribing information, Novo Nordisk

Next